Cargando…

Clinical significance of histopathological features of paired recurrent gliomas: a cohort study from a single cancer center

OBJECTIVE: To explore the histopathological characteristics of paired recurrent gliomas and their clinical significance. METHODS: Glioma patients who received both primary surgery and reoperation when recurrence at Sun Yat-sen University Cancer Center from June 2001 to June 2019 were enrolled. Clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Cong, Xi, Shaoyan, Chen, Yingshen, Guo, Chengcheng, Zhang, Ji, Yang, Qunying, Wang, Jian, Sai, Ke, Zeng, Jing, Wang, Jing, Zhang, Zhiqiang, Ke, Chao, Chen, Zhongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811748/ https://www.ncbi.nlm.nih.gov/pubmed/36597096 http://dx.doi.org/10.1186/s12885-022-10484-9

Ejemplares similares

Identify glioma recurrence and treatment effects with triple-tracer PET/CT
por: Li, Cong, et al.
Publicado: (2021)

TIPS-05 ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY FOLLOWING RADIOTHERAPY IN NEWLY DIAGNOSED LOW-GRADE GLIOMA PATIENT WITH RESIDUE TUMORS: A MULTICENTER, OPEN LABEL, RANDOMIZED TRIAL
por: Chen, Zhongping, et al.
Publicado: (2023)

SYST-04 PRELIMINARY REPORT OF A CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICIENCY OF NEOADJUVANT CAMRELIZUMAB AND APATINIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS: A PROSPECTIVE, PHASE II, SINGLE-ARM STUDY
por: Lin, Fuhua, et al.
Publicado: (2022)

Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China
por: Xi, Shaoyan, et al.
Publicado: (2019)

TIPS-13 A PHASE II STUDY OF NEOADJUVANT CAMRELIZUMAB AND APATINIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS
por: Guo, Chengcheng, et al.
Publicado: (2023)

TIPS-12 PHASE I CLINICAL STUDY OF TG02 CAPSULE IN THE TREATMENT OF RECURRENT HIGH-GRADE GLIOMAS WITH FAILED TMZ TREATMENT
por: Guo, Chengcheng, et al.
Publicado: (2023)

Expression of CPEB4 in Human Glioma and Its Correlations With Prognosis
por: Hu, Wanming, et al.
Publicado: (2015)

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
por: Yang, Qunying, et al.
Publicado: (2021)

LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis
por: Cai, Haiping, et al.
Publicado: (2020)

CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas
por: Li, Depei, et al.
Publicado: (2021)

Outcome of surgical resection for brain metastases and radical treatment of the primary tumor in Chinese non–small-cell lung cancer patients
por: Li, Zhenye, et al.
Publicado: (2015)

Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas
por: Li, Depei, et al.
Publicado: (2019)

Clinical significance of vasculogenic mimicry in human gliomas
por: Liu, Xiao-mei, et al.
Publicado: (2011)

The pseudogene PRELID1P6 promotes glioma progression via the hnHNPH1-Akt/mTOR axis
por: Xi, Shaoyan, et al.
Publicado: (2021)

GCT-30. TREATMENT OF PRIMARY INTRACRANIAL GERM CELL TUMORS: SINGLE INSTITUTION EXPERIENCE OF 74 CASES WITHOUT HISTOLOGICAL CONFIRMATION
por: Guo, Chengcheng, et al.
Publicado: (2020)

Predicting the recurrence and overall survival of patients with glioma based on histopathological images using deep learning
por: Luo, Chenhua, et al.
Publicado: (2023)

SYST-10 CSNO2012001 STUDY: A PHASE III TRIAL ON ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY WITH OR WITHOUT INTERFERON-ALPHA IN NEWLY DIAGNOSED HIGH-GRADE GLIOMAS
por: Chen, Zhongping, et al.
Publicado: (2022)

Dual-energy spectral CT quantitative parameters for the differentiation of Glioma recurrence from treatment-related changes: a preliminary study
por: Lv, Yanchun, et al.
Publicado: (2020)

Corrigendum: Predicting the recurrence and overall survival of patients with glioma based on histopathological images using deep learning
por: Luo, Chenhua, et al.
Publicado: (2023)

Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma
por: Ni, Xiangrong, et al.
Publicado: (2022)

Whole exome sequencing reveals the genetic heterogeneity and evolutionary history of primary gliomas and matched recurrences
por: Xu, Peng-Fei, et al.
Publicado: (2022)

Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
por: Zhang, Honghong, et al.
Publicado: (2017)

Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features
por: Zhang, Longbo, et al.
Publicado: (2019)

OTEH-6. Algorithmic approach to characterize post-treatment recurrent glioma using RNA sequencing and quantitative histopathology
por: Argenziano, Michael, et al.
Publicado: (2021)

MDB-31. PRELIMINARY STUDY ON BIOLOGICAL SIGNIFICANCE OF WTX G435D MUTATION IN MEDULLOBLASTOMA
por: Hu, Yuanjun, et al.
Publicado: (2023)

Chemotherapy for gliomas in mainland China: An overview
por: SAI, KE, et al.
Publicado: (2013)

Practice of the New Integrated Molecular Diagnostics in Gliomas: Experiences and New Findings in a Single Chinese Center
por: Hu, Wan-Ming, et al.
Publicado: (2020)

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma
por: Blobner, Jens, et al.
Publicado: (2023)

Dynamic analysis of immune status in patients with intracranial germ cell tumor and establishment of an immune risk prognostic model
por: Wang, Hairong, et al.
Publicado: (2022)

Histopathological analysis of in vivo specimens of recurrent aneurysms after coil embolization
por: Wang, Chao, et al.
Publicado: (2022)

Comparison of Immune Checkpoint Molecules PD-1 and PD-L1 in Paired Primary and Recurrent Glioma: Increasing Trend When Recurrence
por: Yu, Wei, et al.
Publicado: (2022)

Expression of TXLNA in brain gliomas and its clinical significance: a bioinformatics analysis
por: Hu, Bowen, et al.
Publicado: (2023)

Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: A systematic review
por: Duan, Zhiqing, et al.
Publicado: (2022)

Hypoxia induced LBH overexpression accelerates malignant progression in glioma
por: Zhang, Ke-Nan, et al.
Publicado: (2019)

Prognostic significance of cancer stemness‐associated genes in patients with gliomas
por: Qu, Shanqiang, et al.
Publicado: (2020)

Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas
por: Angelopoulou, Efthalia, et al.
Publicado: (2019)

Prediction of early-stage melanoma recurrence using clinical and histopathologic features
por: Wan, Guihong, et al.
Publicado: (2022)

MiR-181b sensitizes glioma cells to teniposide by targeting MDM2
por: Sun, Yan-chang, et al.
Publicado: (2014)

Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060)
por: Li, Meichen, et al.
Publicado: (2022)

Clinical and histopathologic features of sodium taurocholate cotransporting polypeptide deficiency in pediatric patients
por: Dong, Chen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_trvguhn47nf744lutc7uip6rof